Re: M.I.T. - Selecta Biosciences, Inc. Exclusive Patent License Agreement,Exclusive Patent License Agreement • May 24th, 2016 • Selecta Biosciences Inc • Pharmaceutical preparations
Contract Type FiledMay 24th, 2016 Company IndustryThis letter amendment (“Letter Amendment”) is in reference to the Exclusive Patent License Agreement by and between the Massachusetts Institute of Technology (“MIT”) and Selecta Biosciences, Inc. (“Selecta”), effective November 25, 2008, as amended by a First Amendment dated January 12, 2010, (the “MIT License Agreement”). Capitalized terms that are used but not otherwise defined herein shall have the meanings given to such terms in the MIT License Agreement.
Re: M.I.T. - Selecta Biosciences, Inc. Exclusive Patent License Agreement,Exclusive Patent License Agreement • March 18th, 2016 • Selecta Biosciences Inc • Pharmaceutical preparations
Contract Type FiledMarch 18th, 2016 Company IndustryThis letter amendment (“Letter Amendment”) is in reference to the Exclusive Patent License Agreement by and between the Massachusetts Institute of Technology (“MIT”) and Selecta Biosciences, Inc. (“Selecta”), effective November 25, 2008, as amended by a First Amendment dated January 12, 2010, (the “MIT License Agreement”). Capitalized terms that are used but not otherwise defined herein shall have the meanings given to such terms in the MIT License Agreement.